1. Home/
  2. Compounds/
  3. navitoclax:piperlongumine (1:1 mol/mol)

navitoclax:piperlongumine (1:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2navitoclax:piperlongumine (1:1 mol/mol)
PharmacoGx navitoclax:piperlongumine (1:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to navitoclax:piperlongumine (1:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA SPHK2 CTRPv2 pan-cancer AAC 0.12 0.001
mRNA SRRM4 CTRPv2 pan-cancer AAC 0.13 0.001
mRNA TMEM89 CTRPv2 pan-cancer AAC 0.12 0.001
mRNA CCAR2 CTRPv2 pan-cancer AAC 0.12 0.001
mRNA CDC7 CTRPv2 pan-cancer AAC 0.12 0.001
mRNA VPS37D CTRPv2 pan-cancer AAC 0.12 0.001
mRNA ZMYM2 CTRPv2 pan-cancer AAC 0.12 0.001
mRNA USP13 CTRPv2 pan-cancer AAC 0.12 0.001
mRNA CTNNA2 CTRPv2 pan-cancer AAC 0.12 0.001
mRNA GHITM CTRPv2 pan-cancer AAC -0.12 0.001
Download CSV